Trial intelligence / Profile preview

OVID: Oral vs IV Dexamethasone in Pneumonia

NCT01390012Phase 3Completed

Start
Aug 2011
Primary completion
Oct 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, open-label trial of dexamethasone in community acquired pneumonia (CAP). Primary endpoint: Area Under the Concentration time curve. Started Aug 2011; status: completed.

02

Drugs

dexamethasone
03

Conditions

community acquired pneumonia (CAP)

Beyond the preview

Go deeper on NCT01390012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01390012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call